Could a common heart pill delay Parkinson's? small study hints at possibility

NCT ID NCT03775096

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether carvedilol, a drug used for heart failure, can reverse early heart changes seen in people with a sleep disorder that puts them at high risk for Parkinson's disease. Fifteen participants with REM sleep behavior disorder or reduced sense of smell will take carvedilol for a year. The goal is to see if the drug improves heart imaging results and possibly slows down brain changes linked to Parkinson's.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRE-MOTOR PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Michele L Lima Gregorio

    Los Angeles, California, 90046, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.